One year following the publication of the first legal regulations governing the creation of Science and Technology Parks; University - Science, Technology and Innovation – Production Interface Companies; and the Programs and Projects system, the country is moving forward in transforming our Science, Technology and Innovation System (STI)
november 30, 2020@ 11:11:47 | Orfilio Peláez
Industrial production has begun of Cuba’s candidate vaccines Soberana 02 and Abdala (CIGB-66), two of the four developed on the island to combat COVID-19, with progress advancing at BioCubaFarma facilities
february 18, 2021@ 10:02:47 | Orfilio Peláez
The priority given by the Revolution to creating the human capital necessary for the country’s scientific development made it possible for Cuba to effectively respond to the health emergency
january 13, 2021@ 08:01:03 | Orfilio Peláez
Novel drug developed at Cuba’s Center for Molecular Immunology for the treatment of lymphomas and leukemia, now being used with COVID-19 patients
may 15, 2020@ 13:05:07 | Orfilio Peláez
In the year 2020, BioCubaFarma Pharmaceutical and Biotechnological Business Group has strengthen its working ties with universities countrywide.
november 12, 2020@ 13:11:14 | Orfilio Peláez
Cuba’s Neurosciences Center and Medical Imaging Society launch project to perfect the use of x-rays and CAT scans in the diagnosis, prognosis and follow-up of COVID-19 patients
november 18, 2021@ 11:11:58 | Orfilio Peláez
A series of research conducted in the last 20 years to evaluate the influence of architectural and urban design on the indoor thermal environment and energy consumption in Cuba’s climate conditions, especially on non-residential buildings such as hotel management and service facilities, institutions and schools, to name a few, won one of the 78 national awards of the Academy of Sciences 2021, in the category of Technical Sciences.
october 11, 2022@ 11:10:26 | Orfilio Peláez
Cuban ongoing projects to have a system for rapid diagnosis of dengue and a preventive vaccine against this disease show important advances, which could translate into concrete results for this year, confirmed authorities of the Business Group of the Biotechnological and Pharmaceutical Industries (BioCubaFarma in Spanish).
february 22, 2023@ 10:02:49 | Orfilio Peláez
Dr. Eduardo Martínez Díaz, president of the BioCubaFarma enterprise group outlines Cuba’s work in the field of vaccine production over the last 30 years
october 21, 2020@ 08:10:05 | Orfilio Peláez
Specialists at the Pedro Kourí Institute of Tropical Medicine discuss the country's strategy to confront the global pandemic, and clarify protocols designed by the Ministry of Public Health to prevent and control Covid-19
march 30, 2020@ 12:03:53 | Abel Reyes Montero y Orfilio Peláez